Andrea Marzi focuses on Virology, Ebola virus, Virus, Immunology and Coronavirus. Many of her research projects under Virology are closely connected to Filoviridae with Filoviridae, tying the diverse disciplines of science together. Ebola Hemorrhagic Fever, Ebolavirus and Marburgvirus are the core of her Ebola virus study.
Her research investigates the connection between Ebolavirus and topics such as Immune system that intersect with problems in Inflammation. In her study, Virus classification is inextricably linked to Virulence, which falls within the broad field of Virus. Her Mutation study also includes fields such as
Andrea Marzi mainly focuses on Virology, Ebola virus, Ebolavirus, Vesicular stomatitis virus and Virus. Her Virology research is multidisciplinary, relying on both Antibody and Immunology. Her Ebola virus study which covers Immune system that intersects with Antigen.
Her research investigates the connection with Ebolavirus and areas like Viral load which intersect with concerns in Viremia. Andrea Marzi usually deals with Vesicular stomatitis virus and limits it to topics linked to Microbiology and VP40. Her work carried out in the field of Virus brings together such families of science as Cell biology, Recombinant DNA and Virulence.
Her scientific interests lie mostly in Ebola virus, Virology, Outbreak, Vesicular stomatitis virus and Virus. Her Ebola virus research includes themes of Antibody, Immune system, Glycoprotein and Vaccination. Her research on Virology often connects related areas such as Immunogenicity.
Her work in the fields of Zaire ebolavirus overlaps with other areas such as Health care, Coronavirus and Cell type. The various areas that Andrea Marzi examines in her Vesicular stomatitis virus study include Endocytosis, Innate immune system, Fc receptor and Cell biology. The Antibody-dependent enhancement, Highly pathogenic and Viral entry research Andrea Marzi does as part of her general Virus study is frequently linked to other disciplines of science, such as Public health, therefore creating a link between diverse domains of science.
Andrea Marzi mostly deals with Ebola virus, Virology, Pathogenesis, Outbreak and Clinical trial. Her research integrates issues of Vesicular stomatitis virus and Vaccination in her study of Ebola virus. Her Vesicular stomatitis virus study combines topics from a wide range of disciplines, such as Ebola vaccine and Zaire ebolavirus.
Her Vaccination study integrates concerns from other disciplines, such as Ebola virus infection, Influenza A virus subtype H5N1, Immunity and Hemagglutinin. Her work on Viral entry as part of general Virology study is frequently linked to Cell type and Coronavirus, therefore connecting diverse disciplines of science. Her Outbreak research integrates issues from Infectious disease, Lineage, Virus genetics and Mutation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.
Michael Letko;Andrea Marzi;Vincent Munster.
Nature microbiology (2020)
DC-SIGN and DC-SIGNR Interact with the Glycoprotein of Marburg Virus and the S Protein of Severe Acute Respiratory Syndrome Coronavirus
Andrea Marzi;Thomas Gramberg;Graham Simmons;Peggy Möller.
Journal of Virology (2004)
Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor.
Heike Hofmann;Martina Geier;Andrea Marzi;Mandy Krumbiegel.
Biochemical and Biophysical Research Communications (2004)
DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets
Chawaree Chaipan;Elizabeth J. Soilleux;Peter Simpson;Heike Hofmann;Heike Hofmann.
Journal of Virology (2006)
Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis
Paulina Aleksandrowicz;Andrea Marzi;Nadine Biedenkopf;Nadine Beimforde.
The Journal of Infectious Diseases (2011)
Proteolytic Activation of the 1918 Influenza Virus Hemagglutinin
Chawaree Chaipan;Darwyn Kobasa;Darwyn Kobasa;Stephanie Bertram;Ilona Glowacka.
Journal of Virology (2009)
S Protein of Severe Acute Respiratory Syndrome-Associated Coronavirus Mediates Entry into Hepatoma Cell Lines and Is Targeted by Neutralizing Antibodies in Infected Patients
Heike Hofmann;Kim Hattermann;Andrea Marzi;Thomas Gramberg.
Journal of Virology (2004)
Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates
Andrea Marzi;Flora Engelmann;Friederike Feldmann;Kristen Haberthur.
Proceedings of the National Academy of Sciences of the United States of America (2013)
VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain
Andrea Marzi;Shelly J. Robertson;Elaine Haddock;Friederike Feldmann.
Cellular p32 Recruits Cytomegalovirus Kinase pUL97 to Redistribute the Nuclear Lamina
Manfred Marschall;Andrea Marzi;Patricia aus dem Siepen;Ramona Jochmann.
Journal of Biological Chemistry (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: